Alvotech
ALVOW- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001898416
No open-market purchases or sales by Alvotech insiders were filed in the last 90 days; 7 institutions reported holding it in 13F filings for Q2 2026, worth $1.16M in total; Oaktree Capital is the only superinvestor holding it.
Other share classesALVO
13F holders, Q2 2025
Institutional positions in Alvotech as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 11
- 0 vs. Q1 2025
- Shares held
- 5.16M
- +2.47K (0.0%) vs. Q1 2025
- Total value
- $9.09M
- +$1.30M (+16.6%) vs. Q1 2025
- New holders
- 1
- 2 more added
- Sold out
- 1
- 3 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALVOW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 7 | $1.16M |
| Q1 2026 | 6 | $1.29M |
| Q4 2025 | 8 | $3.30M |
| Q3 2025 | 10 | $7.74M |
| Q2 2025 | 11 | $9.09M |
| Q1 2025 | 11 | $7.80M |
| Q4 2024 | 10 | $16.3M |
| Q3 2024 | 10 | $15.7M |
| Q2 2024 | 12 | $15.8M |
| Q1 2024 | 12 | $22.4M |
| Q4 2023 | 12 | $14.4M |
| Q3 2023 | 13 | $9.88M |
| Q2 2023 | 14 | $7.22M |
| Q1 2023 | 15 | $13.3M |
| Q4 2022 | 23 | $5.39M |
| Q3 2022 | 26 | $4.54M |
| Q2 2022 | 29 | $5.40M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Alvotech; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Oaktree Capital Management LPSuperinvestorOaktree Capital | 4,666,667 | $8.24M | 0.16% | 00.0% | Unchanged |
| Linden Advisors LP | 252,884 | $452.7K | 0.00% | 00.0% | Unchanged |
| Arena Capital Advisors, LLC- CA | 60,714 | $107.2K | 0.15% | 00.0% | Unchanged |
| Jane Street Group, LLC | 56,260 | $95.6K | 0.00% | −10.0% | Reduced |
| Sculptor Capital LP | 49,739 | $87.8K | 0.00% | −200−0.4% | Reduced |
| Moore Capital Management, LP | 50,000 | $80.0K | 0.00% | 00.0% | Unchanged |
| Bluefin Capital Management, LLC | 12,608 | $16.8K | 0.01% | +12,608 | New |
| Clear Street LLC | 5,828 | $9.91K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,673 | $3.56K | 0.00% | +1,123+72.5% | Added |
| Royal Bank of Canada | 1,397 | $2.00K | 0.00% | +1,000+251.9% | Added |
| Bank of America Corp | 199 | $265 | 0.00% | −1−0.5% | Reduced |
| CSS LLC | 0 | $0 | 0.00% | −12,058−100.0% | Sold out |